Insider Stock Trading History of Velleca Mark A.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Velleca Mark A. since year 2005. The trader's CIK number is 1706847. At the time of this reporting, Velleca Mark A. is the President and CEO of G1 Therapeutics, Inc. . (stock ticker symbol GTHX). See this page for all insider trading activities at G1 Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Velleca Mark A. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-05-31 GTHX G1 Therapeutics, Inc. Option Ex 10,000 .39 3,900
2018-05-15 GTHX G1 Therapeutics, Inc. Sale 7,500 46.40 348,015
2018-05-15 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2018-04-16 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2018-04-16 GTHX G1 Therapeutics, Inc. Sale 7,500 36.33 272,460
2018-03-15 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2018-03-15 GTHX G1 Therapeutics, Inc. Sale 7,500 38.20 286,470
2018-02-15 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2018-02-15 GTHX G1 Therapeutics, Inc. Sale 7,500 20.00 150,015
2018-01-16 GTHX G1 Therapeutics, Inc. Sale 7,500 22.99 172,395
2018-01-16 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2017-12-18 GTHX G1 Therapeutics, Inc. Option Ex 7,500 3.72 27,900
2017-12-18 GTHX G1 Therapeutics, Inc. Sale 7,500 20.01 150,105

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Velleca Mark A. (President and CEO of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.